Evidence map›Paper›PMID 38873680›Full record

ArticleHeliyon2024

Enhancing vaccination strategies for epidemic control through effective lockdown measures.

Abhi Chakraborty, K M Ariful Kabir

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Abhi ChakrabortyDepartment of Mathematics, Bangladesh University of Engineering and Technology, Dhaka, 1000, Bangladesh.
K M Ariful KabirDepartment of Mathematics, Bangladesh University of Engineering and Technology, Dhaka, 1000, Bangladesh.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Evolutionary epidemiology models have substantially impacted the study of various infections and prevention methods in the biology field. These models are called Susceptible, Lockdown, Vaccinated, Infected, and Recovered (SLVIR) epidemic dynamics. We explore how human behavior, particularly in the context of disease transmission, is influenced by two intervention strategies: vaccination and lockdown, both of which are grounded in the principles of evolutionary game theory (EGT). This comprehensive study using evolutionary game theory delves into the dynamics of epidemics, explicitly focusing on the transition rate from susceptibility to immunity and susceptibility to lockdown measures. Our research involves a thorough analysis of the structural aspects of the SLVIR epidemic model, which delineates disease-free equilibria to ensure stability in the system. Our investigation supports the notion that implementing lockdown measures effectively reduces the required level of vaccinations to curtail the prevalence of new infections. Furthermore, it highlights that combining both strategies is particularly potent when an epidemic spreads rapidly. In regions where the disease spreads comparatively more, our research demonstrates that lockdown measures are more effective in reducing the spread of the disease than relying solely on vaccines. Through significant numerical simulations, our research illustrates that integrating lockdown measures and efficient vaccination strategies can indirectly lower the risk of infection within the population, provided they are both dependable and affordable. The outcomes reveal a nuanced and beneficial scenario where we examine the interplay between the evolution of vaccination strategies and lockdown measures, assessing their coexistence through indicators of average social payoff.

Indexed as

EpidemiologyEvolutionary game theoryLockdown gameVaccination game

Identifiers

PMID38873680
PMCPMC11170194

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.